Healthcare Nanotechnology Market Size, Share & Industry Analysis, By Application (Diagnosis, Prevention, Treatment), By Diseases & Disorder (Neurological Disorder, Oncological Diseases, Cardiovascular Diseases & Disorders, Infectious Diseases, Gastrointestinal Diseases , Others (Orthopaedic Diseases, Diabetes)), By Type (Organic, Inorganic, Carbon-based) And Regional Forecast, 2024-2032

Nanotechnology is the science of materials at the molecular or subatomic level. It has several applications in healthcare. It is used in tumor surgeries, and it is widely used for the prevention, diagnosis, and treatment of various diseases and disorders such as cancer and cardiovascular. Many available treatments are improving with the help of nanotechnology because globally, many countries’ researchers and medical practitioners are adopting nanotechnology for better results. For instance, nanorobots are used by medical practitioners for precise treatment, instead of handling traditional instruments nowadays, surgeons are using joysticks for surgeries. Along with these factors growing prevalence of cancer & cardiovascular diseases and the growing preference for personalized medicines are leading factors for boosting the market. Despite this, there are some restraining factors, such as the cost associated with nanotechnology is huge. Thus underdeveloped region countries cannot afford the research and development cost of healthcare nanotechnologies due to lack of funding and infrastructure. Furthermore, stringent government regulations of countries for approval process limits the growth of the nanotechnology market.

Key Market Driver -

Growing prevalence of cancer and cardiovascular diseases. Growing preference for personalized medicines.

Key Market Restraint -

High cost of nanotechnology. Stringent government regulations for approval process.

Market Segmentation:

Globally, the healthcare nanotechnology market can be segmented on the basis of the application, diseases indication, type and region. Based on the application, the market can be segmented into diagnosis, prevention, treatment. Based on diseases and disorders, the market is segmented into neurological disorder, oncological diseases, cardiovascular disease and disorders, infectious diseases, gastrointestinal diseases and others. Based on types of Nano particles, the market is segmented into organic, inorganic and carbon based. Geographically, the healthcare nanotechnology market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Key Players Covered:

Some of the major companies that are present in the healthcare nanotechnology market are Stryker, GENERAL ELECTRIC COMPANY, Johnson & Johnson Services, Inc., 3M, Sanofi, F. Hoffmann-La Roche Ltd, Ionic Pharmaceuticals, Inc., Mallinckrodt plc, Nanobiosym, Inc., Nanobiotix and other prominent players.

Key Insights:

• Key Industry Trends


• Technological Advancements in healthcare nanotechnology


• New Product Launches


• Key Industry Developments Mergers, Acquisitions, And Collaborations


• Impact of Covid-19 on the market

Regional Analysis:

Geographically, the healthcare nanotechnology market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is anticipated to account for the majority of the share of the healthcare nanotechnology market. The dominance of the region is attributable to countries’ high investment in research and development activities of nanotechnology and the presence of key players. Europe is expected to hold the second-largest market share during the forecast period due to technological advancement and improvement in drug bioavailability and drug administration. Furthermore, countries in Europe also investing in research and development to a great extent. On the other hand, Asia Pacific is expected to grow with the highest growth rate during the forecast period owing to an increase in the aging population and development in infrastructure and research collaboration of key players. The Latin America and the Middle East & Africa markets are expected to showcase substantial growth during the forecast period. This is due to countries in this region accepting nanotechnology in healthcare, but expenditure on research and development of these countries is still less compared to other regions. In African countries, safety in the handling of Nano-materials is of major concern because of the lack of handling equipment and infrastructure.

To gain extensive insights into the market, Request for Customization

Segmentation

Healthcare Nanotechnology Market Industry Developments

• November 2020, BioNtech and Pfizer announced the result of two nanoparticle-based vaccines. In addition, in May 2020, Epidemic Preparedness Innovations (CEPI) announced USD 384 million for the development of Novavax, a nanoparticle-based COVID-19 vaccine.


• July 2020, the US-based and Kerala-based start-up, LeadInvent, in India, developed a gel using nanoparticles that can kill the remaining cancer cells in patients with brain cancer, especially glioblastoma, after surgery.